Pharmacy middlemen try to pull Utah opioid suit into federal court

Pharmacy middlemen try to pull Utah opioid suit into federal court

Two pharmacy benefit mangers claim their work for federal healthcare programs gives the case a place in federal court, not Utah state court.(CN) — The path from a pharmacy counter to an illegal drug market was at the heart of a debate Tuesday over which court Utah can pursue a public nuisance and consumer sales practice lawsuit against two pharmacy benefit managers.Express Scripts and Optum asked a 10th Circuit panel put the case back into federal court instead of Utah state court.The prescription-drug benefit companies argue that the lawsuit falls under federal jurisdiction because they provided prescription drug benefits to federal programs for employees and veterans, and those prescriptions overlapped with services they provided to private healthcare plans.“The question before the court today is not whether the state’s lawsuit may proceed, but where it will be decided,” attorney Jonathan Cooper, of Quinn Emanuel Urquhart & Sullivan representing the defendants, said. “Because this case at least relates to defendants’ conduct under federal officers, it belongs in federal court under the federal officer removal statute.”However, Utah and its Division of Consumer Protection explicitly excluded the companies’ work as federal officers in a disclaimer written in the complaint.The pharmacy benefit managers argued that U.S. District Judge Jill Parrish should not have held this disclaimer was enough to defeat federal jurisdiction when she sent the case back to state court. The Barack Obama appointee’s ruling was inconsistent with rulings from the Second, Sixth and Eighth circuits, Cooper argued.“The state challenges conduct performed indivisibly for federal and non-federal clients of the [pharmacy benefits manager] defendants,” he argued to the three-judge panel. “As the Eighth Circuit put it in its Griffin decision, no disclaimer, however worded, can sever the connection between the state’s claims and the defendant’s federal work.”Utah claims the defendants oversupplied opioids in the state, which inevitably led to an increase in addiction and death. Cooper argued that it’s impossible to trace which plans those opioids came from.“You can’t disaggregate which ones came from federal plans and which ones from non-federal plans when they’ve all passed through these allegedly illegal secondary markets, where they commingle,” Cooper said.Additionally, Express Scripts and Optum both say that the federal court should have issued an automatic stay following their appeal of the remand order under the federal officer removal statute, consistent with rulings from other appellate courts.Express Scripts and Optum offered formularies and pharmacy-benefit plans to thousands of pharmacies that resulted in a dramatic oversupply of opioids in the U.S. and Utah, the state says in its complaint, filed in Utah’s Third Judicial District in December 2024.The state claims the defendants profited greatly, at the expense of Utah citizens, from the quadrupling of the amount of opioids prescribed in the country and the tripling of the number of Utahns who died from prescription drug overdoses in recent years.It also accuses the defendants of abusing their role as pharmacy benefit managers — third-party companies that manage prescription drug-benefit plans sponsored by health insurance companies — to exacerbate the opioid crisis.Sarah Goldberg with the Utah Attorney General’s Office likened the case’s removal from state to federal court to a car company that manufactures engines for civilian and military vehicles.“If someone is injured because of an engine malfunction in their private big truck, I don’t think that should also fall under the federal officer removal statute,” she argued.U.S. Circuit Judge Robert Bacharach, also an Obama appointee, seemed reluctant to affirm the lower court’s order, considering the other appellate rulings.“Generally, when all of the circuits are going one way, we usually are at least reticent at a judicial modesty of creating a circuit split,” Bacharach said.But Goldberg argued that there is already a circuit split in a 2025 Ninth Circuit decision in a similar California lawsuit against Express Scripts.“The courts have gone both ways on both of these issues,” she said. “We urge the court to follow the Ninth Circuit and affirm the district court’s order.”Bacharach was joined by U.S. Circuit Judges Nancy Moritz, another Obama appointee, and Allison Eid, a Donald Trump appointee.Subscribe to our free newslettersOur weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.Additional Reads

Original Source

Read the full article at Courthousenews →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.